Characteristics of chronic pain patients who take opioids and persistently report high pain intensity

Regional Anesthesia and Pain Medicine

Volumn 39, Issue 1, 2014, Pages 13-17

  Wasserman, Ronald A ^a   Brummett, Chad M ^a   Goesling, Jenna ^a   Tsodikov, Alex ^b   Hassett, Afton L ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OPIATE;

ABDOMINAL PAIN; ADULT; ANALGESIA; ANXIETY; ARTICLE; BRIEF PAIN INVENTORY; CHRONIC PAIN; CROSS-SECTIONAL STUDY; DEPRESSION; DISEASE ASSOCIATION; DISEASE SEVERITY; FACE PAIN; FEMALE; FIBROMYALGIA; FUNCTIONAL STATUS; GENITOURINARY PAIN; HEADACHE; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MOOD; MUSCULOSKELETAL PAIN; NEUROPATHIC PAIN; PAIN; PAIN ASSESSMENT; PELVIC PAIN; PERIPHERAL NERVE PAIN; PHENOTYPE; PRIORITY JOURNAL; QUESTIONNAIRE; SELF REPORT; SPINE PAIN;

ADULT; ANALGESICS, OPIOID; CHRONIC PAIN; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PAIN MEASUREMENT; SELF REPORT;

EID: 84892181936     PISSN: 10987339     EISSN: 15328651     Source Type: Journal    
DOI: 10.1097/AAP.0000000000000024     Document Type: Article

References (26)

1. Brown RT, Zuelsdorff M, Fleming M. Adverse effects and cognitive function among primary care patients taking opioids for chronic nonmalignant pain. J Opioid Manag. 2006;2:137-146
2. Edwards RR, Wasan AD, Michna E, Greenbaum S, Ross E, Jamison RN. Elevated pain sensitivity in chronic pain patients at risk for opioid misuse. J Pain. 2011;12:953-963
3. Lenssinck ML, Burdorf A, Boonen A, Gignac MA, Hazes JM, Luime JJ. Consequences of inflammatory arthritis for workplace productivity loss and sick leave: A systematic review. Ann Rheum Dis. 2013;72:493-505
4. Manchikanti L, Abdi S, Atluri S, et al. American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part 2 - guidance. Pain Physician. 2012;15:S67-S116
5. Brummett CM, Clauw DJ. Fibromyalgia: A primer for the anesthesia community. Curr Opin Anaesthesiol. 2011;24:532-539
6. Williams DA, Clauw DJ. Understanding fibromyalgia: Lessons from the broader pain research community. J Pain. 2009;10:777-791
7. Woolf CJ. Central sensitization: Implications for the diagnosis and treatment of pain. Pain. 2011;152:S2-S15
8. Harris RE, Clauw DJ, Scott DJ, McLean SA, Gracely RH, Zubieta JK. Decreased central m-opioid receptor availability in fibromyalgia. J Neurosci. 2007;27:10000-10006
9. Clauw DJ. Fibromyalgia: An overview. Am J Med. 2009;122:S3-S13
10. Baraniuk JN, Whalen G, Cunningham J, Clauw DJ. Cerebrospinal fluid levels of opioid peptides in fibromyalgia and chronic low back pain. BMC Musculoskelet Disord. 2004;5:48
11. Lee M, Silverman SM, Hansen H, Patel VB, Manchikanti L. A comprehensive review of opioid-induced hyperalgesia. Pain Physician. 2011;14:145-161
12. Brummett CM, Goesling J, Tsodikov A, Meraj TS, Wasserman RA, Clauw DJ, Hassett AL. Prevalence of the fibromyalgia phenotype in spine pain patients presenting to a tertiary care pain clinic and the potential implications for peripherally directed treatments. Arthritis Rheum. 2013;65: In Press
13. Wolfe F, Clauw DJ, Fitzcharles MA, et al. Fibromyalgia criteria and severity scales for clinical and epidemiological studies: A modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia. J Rheumatol. 2011;38:1113-1122
14. Hassett AL, Wasserman R, Goesling J, Rakovitis K, Shi B, Brummett CM. Longitudinal assessment of pain outcomes in the clinical setting: Development of the "APOLO" electronic data capture system. Reg Anesth Pain Med. 2012;37:398-402
15. Goesling J, Brummett CM, Hassett AL. Cigarette smoking and pain: Depressive symptoms mediate smoking-related pain symptoms. Pain. 2012;153:1749-1754
16. Hassett AL, Hilliard P, Goesling J, Clauw DJ, Harte SE, Brummett CM. Reports of chronic pain in childhood and adolescence among patients at a tertiary care pain clinic. J Pain. 2013;14:1390-1397
17. Cleeland CS, Ryan KM. Pain assessment: Global use of the Brief Pain Inventory. Ann Acad Med Singapore. 1994;23:129-138
18. Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Hauser W, Katz RS, Mease P, Russell AS, Russell IJ, Winfield JB. Fibromyalgia criteria and severity scales for clinical and epidemiological studies: A modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia. J Rheumatol. 2011;38:1113-1122
19. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the multicenter criteria committee. Arthritis Rheum. 1990;33:160-172
20. Brummett CM, Hassett AL, Brummett KA, Clauw DJ, Williams DA. The Michigan Body Map and its use in assessing the American College of Rheumatology Survey Criteria for Fibromyalgia. Arthritis Rheum. 2011;62:S744
21. Freynhagen R, Baron R, Gockel U, Tolle TR. painDETECT: A new screening questionnaire to identify neuropathic components in patients with back pain. Curr Med Res Opin. 2006;22:1911-1920
22. Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand. 1983;67:361-370
23. Cella D, Riley W, Stone A, et al. The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005-2008. J Clin Epidemiol. 2010;63:1179-1194
24. Friedberg F, Williams DA, Collinge W. Lifestyle-oriented non-pharmacological treatments for fibromyalgia: A clinical overview and applicationswith home-based technologies. JPainRes. 2012;5:425-435
25. Collett BJ. Opioid tolerance: The clinical perspective. Br J Anaesth. 1998;81:58-68
26. Chu LF, Angst MS, Clark D. Opioid-induced hyperalgesia in humans: Molecular mechanisms and clinical considerations. Clin J Pain. 2008;24:479-496